Loading…
SMA Treatment Acceleration Act of 2009
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2010 · fourth_quarter · Health Issues
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy and H.R. 3790, Competitive Bidding Repeal
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases
Client expense: Not reported · Firm income: $30,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · fourth_quarter · Health Issues
Sought passage of the SMA Treatment Acceleration Act of 2009 (H.R. 2149 / S. 1158).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · fourth_quarter · Health Issues
HR 2149 / S.1158 Spinal Muscular Atrophy Treatment Acceleration Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
Seek support for and passage of the SMA treatment Acceleration Act of 2009 (H.R. 2149 / S. 1158)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · third_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy and H.R. 3790, Competitive Bidding Repeal
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
Seek support for and passage of the SMA Treatment Acceleration Act of 2009 (H.R. 2149 / S. 1158).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · third_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases
Client expense: Not reported · Firm income: $30,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · third_quarter · Health Issues
HR 2149 / S.1158 Spinal Muscular Atrophy Treatment Acceleration Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases
Client expense: Not reported · Firm income: $30,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · second_quarter · Health Issues
HR 2149 / S.1158 Spinal Muscular Atrophy Treatment Acceleration Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy and H1N1 distribution plans for high priority groups
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · first_quarter · Health Issues
H.R. 2149 / S.1158 Spinal Muscular Atrophy Treatment Acceleration Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy, H.R. 3790, Competitive Bidding Repeal Act, and H1N1 distribution plans for high priority groups
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Health Issues
H.R. 2149 / S.1158 2009 Spinal Muscular Atrophy Treatment Acceleration Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · third_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy, and H1N1 distribution plans for high priority groups.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Health Issues
H.R. 2149 / S.1158 2009 Spinal Muscular Atrophy Treatment Acceleration Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · second_quarter · Health Issues
H.R. 2149 / S.1158 2009 Spinal Muscular Atrophy Treatment Acceleration Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, and legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158)
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2009 · second_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
| Democratic |
| NY |
| Dianne Feinstein | Democratic | CA |
| Frank R. Lautenberg | Democratic | NJ |
| Jack Reed | Democratic | RI |
| Jim Webb | Democratic | VA |
| John F. Kerry | Democratic | MA |
| Johnny Isakson | Republican | GA |
| Kay R. Hagan | Democratic | NC |
| Kirsten E. Gillibrand | Democratic | NY |
| Mark R. Warner | Democratic | VA |
| Patty Murray | Democratic | WA |
| Richard Burr | Republican | NC |
| Robert Menendez | Democratic | NJ |
| Robert P. Casey, Jr. | Democratic | PA |
| Roger F. Wicker | Republican | MS |
| Saxby Chambliss | Republican | GA |
| Sheldon Whitehouse | Democratic | RI |
| Sherrod Brown | Democratic | OH |